top of page
Our Investment in Virtual Incision
Reimagining robotic minimally invasive procedures
Virtual Incision is developing the MIRA® (Miniaturized In vivo Robotic Assistant) Platform, a first-of-its-kind miniaturized surgical robotic support device, focusing first on colon resection, with follow-on specialty robots for additional potential applications
Founded in 2006
Partnered in 2012
Shane Farritor PhD, MS
Dmitry Oleynikov MD
“We designed the MIRA Surgical Robotic Platform with the fundamental understanding that minimally invasive procedures offer tremendous benefits to patients,”
Co-Founders Shane Farritor and Dmitry Oleynikov saw an opportunity to improve the technology in surgical robotics. Shane Farritor, Ph.D. is currently a faculty member at the University of Nebraska-Lincoln. Prior to his work at the university, Shane studied at the Kennedy Space Center, Goddard Space Flight Center, and the Jet Propulsion Laboratory.
“We designed the MIRA Surgical Robotic Platform with the fundamental understanding that minimally invasive procedures offer tremendous benefits to patients,” said Virtual Incision president and CEO John Murphy. “We believe our portable and affordable abdominal robot has the potential to bring these benefits to many more patients.”
In 2017, the company raised $18 million in a Series B round of funding. Virtual Incision has recently raised $20 million in a “Series B+” round, which will be used to further pursue regulatory and clinical programs.
bottom of page